Skip to main content

. 1985 Jul;78(7):588–589. doi: 10.1177/014107688507800713

Erroneous diagnosis of phaeochromocytoma in hypertensive patient on labetalol.

P M Bouloux, R M Featherstone, V Clement-Jones, L H Rees, J E Goligher

PMCID: PMC1291184 PMID: 4009571

588

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bouloux P., Perrett D., Besser G. M. Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection. Ann Clin Biochem. 1985 Mar;22(Pt 2):194–203. doi: 10.1177/000456328502200217. [DOI] [PubMed] [Google Scholar]
Hamilton C. A., Jones D. H., Dargie H. J., Reid J. L. Does labetalol increase excretion of urinary catecholamines? Br Med J. 1978 Sep 16;2(6140):800–800. doi: 10.1136/bmj.2.6140.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
Harris D., Richards D. A. Labetalol and urinary catecholamines. Br Med J. 1977 Dec 24;2(6103):1673–1673. doi: 10.1136/bmj.2.6103.1673-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kobayashi K., Miura Y., Tomioka H., Sakuma H., Adachi M., Abe K., Yoshinaga K. Interference with fluorimetric assay of catecholamine by labetalol. Tohoku J Exp Med. 1978 Oct;126(2):201–202. doi: 10.1620/tjem.126.201. [DOI] [PubMed] [Google Scholar]
Lax P., Ruthven C. R., Sandler M. Labetalol and urinary metadrenalines. Br Med J. 1979 Apr 7;1(6168):953–953. doi: 10.1136/bmj.1.6168.953-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
Miano L., Kolloch R., De Quattro V. Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites. Clin Chim Acta. 1979 Jul 16;95(2):211–217. doi: 10.1016/0009-8981(79)90361-9. [DOI] [PubMed] [Google Scholar]
Richards D. A., Harris D. M., Martin L. E. Labetalol and urinary catecholamines. Br Med J. 1979 Mar 10;1(6164):685–685. doi: 10.1136/bmj.1.6164.685-c. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES